AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Feb 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-02-08

Reporting Person: Rosenberg Ellen (General Counsel & Corp. Secy)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-08	Stock Options (right to buy)	$5.16	A	175000	Acquired	2026-02-08	Common Stock (175000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on February 8, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on March 8, 2017, with the final installment vesting on February 8, 2020.